StockCall Early Morning Insight into St. Jude Medical, Hologic, Navidea Biopharma, ResMed, and Edwards Lifesciences

   StockCall Early Morning Insight into St. Jude Medical, Hologic, Navidea
                 Biopharma, ResMed, and Edwards Lifesciences

PR Newswire

LONDON, April 16, 2013

LONDON, April 16, 2013 /PRNewswire/ --

While President Obama's Affordable Care Act (ACA) has been seen by many as
being beneficial to the healthcare industry, the reform has been fiercely
opposed by the medical appliances & equipment industry. This is because
medical appliances & equipment companies have been levied with a 2.3% tax on
total U.S. gross sales of medical devices and equipment under the ACA.
Companies such as St. Jude Medical Inc. (NYSE: STJ), Hologic Inc. (NASDAQ:
HOLX), Navidea Biopharmaceuticals Inc. (AMEX: NAVB), ResMed Inc. (NYSE: RMD),
and Edward Lifesciences Corp. (NYSE: EW) say that the ACA will lead to higher
costs for the industry, and hurt innovation as companies will be forced to
scale back their research and development activities. Shares of medical
appliances & equipment companies ended mostly lower in Monday's trading
session, tracking losses in the broad market. StockCall has issued technical
analysis and charting reports on STJ, HOLX, NAVB, RMD, and EW. Download these
free reports now at

Shares of St. Jude Medical Inc. saw a sharp decline in Monday's trading
session. The stock closed 2.87% lower at $41.26 on above average volume of
2.57 million. Despite the significant drop, St. Jude Medical's shares are
still trading close to their 52-week high of $43.76. The stock has gained
nearly 14.90% so far in 2013, outperforming the S&P 500. However, the stock
has slipped below its 50-day moving average yesterday, which is a bearish
signal. Download the free research on STJ today by registering at

Shares of Hologic Inc. struggled in yesterday's trading session, extending
their losses from last week. The stock ended the day 1.83% lower at $21.50 on
volume of 1.80 million, taking its losses in the last three sessions to nearly
2.50%. Hologic's shares currently have support at around $21.50. The stock has
slipped below its 50-day moving average as a result of recent losses, which is
a bearish signal. The downbeat trend is further confirmed by the stock's MACD
chart. Sign up and have access to our free report on HOLX at

Shares of Navidea Biopharmaceuticals Inc. were among the major losers in the
healthcare sector on Monday. The stock closed 3.88% lower at $2.48 on volume
of 1.37 million, taking its losses in the last three trading sessions to over
6%. Navidea's shares touched an intra-day low of $2.47. The stock is now
trading close to its 52-week low of $2.14. Year-to-date, shares of NAVB have
fallen nearly 12.40%, underperforming the broad market. Sign up and read the
complimentary report on NAVB at

Share of ResMed Inc. also came under pressure on Monday. The stock fell 3.70%
to finish the day at $44.04, which was also its intra-day low. Volume was up
from daily average of 1.06 million to 1.19 million. Despite the sharp decline
on Monday, ResMed's shares are still up more than 6.30% thus far this year.
The stock, however, has slipped below its 50-day moving average, which
indicates that market sentiment has turned bearish. The free report on RMD can
be downloaded by signing up now at

Edward Lifesciences Corp.'s shares fell to an intra-day low of $83.50 before
paring some of the losses to finish the day 1.34% lower at $83.66 on volume of
950,347. Year-to-date, the stock has fallen more than 7.20%, underperforming
the S&P 500. Shares of EW are now trading nearly 24.50% below their 52-week
high. Free report on EW can be accessed by registering at

About is a financial website where investors can have easy, precise
and comprehensive research and opinions on stocks making the headlines. Sign
up today to talk to our financial analyst at 


Contact: Contact Person:William T. Knight, Email:, Contact
Number: +1(646)396-9857 (9:00 am EST - 01:30 pm EST)
Press spacebar to pause and continue. Press esc to stop.